DRUG · Mapped RxNorm record
escitalopram oxalate
Normalized identity: escitalopram oxalate View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
NCT00387348
Study summary
ClinicalTrials.govEscitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Colorectal Cancerverified · MONDO: colorectal cancer
Depressionverified · MONDO: depressive disorder
Esophageal Cancerverified · MONDO: esophageal cancer
Fatigueunresolved
Gallbladder Cancerverified · MONDO: gallbladder cancer
Gastric Cancerverified · MONDO: gastric cancer
Liver Cancerverified · MONDO: liver cancer
Lung Cancerverified · MONDO: lung cancer
Interventions
escitalopram oxalateDRUG · verified · RxNorm: escitalopram oxalate
PlaceboDRUG
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00387348 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.